Supplementary Table from AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table from AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
Authors: Sonya D. Zabludoff, Chun Deng, Michael R. Grondine, Adam M. Sheehy, Susan Ashwell, Benjamin L. Caleb, Stephen Green, Heather R. Haye, Candice L. Horn, James W. Janetka, Dongfang Liu, Elizabeth Mouchet, Shannon Ready, Judith L. Rosenthal, Christophe Queva, Gary K. Schwartz, Karen J. Taylor, Archie N. Tse, Graeme E. Walker, Anne M. White
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361940966